Clinical Effectiveness and Cost-Effectiveness of HIV Pre-Exposure Prophylaxis in Men Who Have Sex with Men: Risk Calculators for Real-World Decision-Making

por Chen, Anders, Dowdy, David W.
Publicado em 2014

Reply to Chen, Song, and Liu

por Hong, Hyejeong, Dowdy, David W
Publicado no Clin Infect Dis (2020)

Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees

por Ilaiwy, Ghassan, Dowdy, David W.
Publicado no J Clin Tuberc Other Mycobact Dis (2021)

The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection

por Dowdy, David W, Chaisson, Richard E
Publicado em 2009

Author reply

por Dowdy, David W, Chaisson, Richard E
Publicado em 2009

Post-2015 tuberculosis strategies in a pre-2015 world

por Dowdy, David W., Chaisson, Richard E.
Publicado no Int J Tuberc Lung Dis (2013)

Measuring success: The challenge of social protection in helping eliminate tuberculosis

por Shete, Priya B., Dowdy, David W.
Publicado no PLoS Med (2017)

Data Needs for Evidence-Based Decisions: A TB Modeler’s “Wish List”

por Dowdy, David W., Dye, Christopher, Cohen, Ted
Publicado em 2013

Mathematical Modelling and Tuberculosis: Advances in Diagnostics and Novel Therapies

por Zwerling, Alice, Shrestha, Sourya, Dowdy, David W.
Publicado no Adv Med (2015)

Serological Testing Versus Other Strategies for Diagnosis of Active Tuberculosis in India: A Cost-Effectiveness Analysis

por Dowdy, David W., Steingart, Karen R., Pai, Madhukar
Publicado em 2011

Is Passive Diagnosis Enough?: The Impact of Subclinical Disease on Diagnostic Strategies for Tuberculosis

por Dowdy, David W., Basu, Sanjay, Andrews, Jason R.
Publicado em 2013

Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?

por Denkinger, Claudia M., Pai, Madhukar, Dowdy, David W.
Publicado em 2014

How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India

por Azman, Andrew S, Golub, Jonathan E, Dowdy, David W
Publicado no BMC Med (2014)

Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India

por Little, Kristen M., Pai, Madhukar, Dowdy, David W.
Publicado no PLoS One (2015)

Cost-Consequence Analysis of Multimodal Interventions with Environmental Components for Pediatric Asthma in the State of Maryland

por Jassal, Mandeep S., Diette, Gregory B., Dowdy, David W.
Publicado no J Asthma (2013)

Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis

por Kendall, Emily A, Fojo, Anthony T, Dowdy, David W
Publicado no Lancet Respir Med (2017)

The Epidemiological Importance of Subclinical Tuberculosis. A Critical Reappraisal

por Kendall, Emily A., Shrestha, Sourya, Dowdy, David W.
Publicado no Am J Respir Crit Care Med (2021)

Cost-Effectiveness of Novel First-Line Therapeutic Regimens for Tuberculosis

por Owens, Jonathan P., Fofana, Mariam O., Dowdy, David W.
Publicado em 2013

The Impact of Novel Tests for Tuberculosis Depends on the Diagnostic Cascade

por Sun, Amanda Y., Denkinger, Claudia M., Dowdy, David W.
Publicado no Eur Respir J (2014)

The burden of transmitted multi-drug resistance among epidemics of tuberculosis: A transmission model

por Kendall, Emily A., Fofana, Mariam O., Dowdy, David W.
Publicado no Lancet Respir Med (2015)